Neo-Concept International Group Holdings Ltd (NCI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Neo-Concept International Group Holdings Ltd (NCI) is between -- to -- according to relative valuation method.

Relative Value

Fair Zone

-----

Current Price：5.06

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Neo-Concept International Group Holdings Ltd (NCI) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Neo-Concept International Group Holdings Ltd (NCI) has a current Price-to-Book (P/B) ratio of 0.62. Compared to its 3-year average P/B ratio of -16.12, the current P/B ratio is approximately -103.85% higher. Relative to its 5-year average P/B ratio of -16.12, the current P/B ratio is about -103.85% higher. Neo-Concept International Group Holdings Ltd (NCI) has a Forward Free Cash Flow (FCF) yield of approximately 51.63%. Compared to its 3-year average FCF yield of -14.69%, the current FCF yield is approximately -451.38% lower. Relative to its 5-year average FCF yield of -14.69%, the current FCF yield is about -451.38% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NCI competitors is 0.20, providing a benchmark for relative valuation. Neo-Concept International Group Holdings Ltd Corp (NCI.O) exhibits a P/S ratio of --, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NCI increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NCI in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NCI currently overvalued or undervalued?

What is Neo-Concept International Group Holdings Ltd (NCI) fair value?

NCI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Neo-Concept International Group Holdings Ltd (NCI) is between to according to relative valuation method.

How does NCI's valuation metrics compare to the industry average?

The average P/S ratio for NCI's competitors is 0.20, providing a benchmark for relative valuation. Neo-Concept International Group Holdings Ltd Corp (NCI) exhibits a P/S ratio of --, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Neo-Concept International Group Holdings Ltd (NCI) as of Mar 02 2026?

As of Mar 02 2026, Neo-Concept International Group Holdings Ltd (NCI) has a P/B ratio of 0.62. This indicates that the market values NCI at 0.62 times its book value.

What is the current FCF Yield for Neo-Concept International Group Holdings Ltd (NCI) as of Mar 02 2026?

As of Mar 02 2026, Neo-Concept International Group Holdings Ltd (NCI) has a FCF Yield of 51.63%. This means that for every dollar of Neo-Concept International Group Holdings Ltd's market capitalization, the company generates 51.63 cents in free cash flow.

What is the current Forward P/E ratio for Neo-Concept International Group Holdings Ltd (NCI) as of Mar 02 2026?

As of Mar 02 2026, Neo-Concept International Group Holdings Ltd (NCI) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Neo-Concept International Group Holdings Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Neo-Concept International Group Holdings Ltd (NCI) as of Mar 02 2026?

As of Mar 02 2026, Neo-Concept International Group Holdings Ltd (NCI) has a Forward P/S ratio of 0.00. This means the market is valuing NCI at $0.00 for every dollar of expected revenue over the next 12 months.

NCI Valuation